Pochiraju Industries Limited. Pochiraju Industries Limited is an India-based company engaged in floriculture (flowers and plants) (fruits and vegetables), and pharmaceutical and bio-pharmaceutical business. The Company's segments include Floriculture, and Pharma & Bio Pharma. Pharmapil is the pharmaceutical division of the Company. Biopil is the biotechnology division of the Company. Agropil is the agricultural division of the Company. The Company outsources other varieties of roses and other flowers, such as Coronations, Chrysanthemums, Tuberoses and Zeberas from growers in India, as well as from Malaysia, Singapore and Australia for its international marketing. The Pharmapil division offers anti-bacterial, antibiotics, antifungal, cardiovascular, antiulcerant, non-steroidal anti-inflammatory drugs (NSAIDs), analgesic and antipyretic, anti-spasmodic and antihistamine products. It manufactures biosimilars, biologicals, therapeutic proteins and monoclonal antibody.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.